Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original application for a generic olmesartan medoxomil product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)